Shihua Lin
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Dual Immunological Prognostic Models for Risk Stratification and Treatment Insights in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: January 05, 2026
Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer.
Journal: Genes & diseases
Published: March 10, 2023
LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases.
Journal: Nucleic acids research
Published: September 08, 2022
Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
Journal: Frontiers in immunology
Published: July 09, 2022
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis.
Journal: Molecular therapy. Nucleic acids
Published: June 08, 2022
Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer.
Journal: Scientific reports
Published: April 26, 2022
Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer.
Journal: Journal of translational medicine
Published: March 12, 2022
Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes.
Journal: Molecular therapy. Nucleic acids
Published: April 25, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026